Research Grade Tibulizumab
Product Sizes
1 mg
£665.00
DHH28810-1MG
5 mg
£1813.00
DHH28810-5MG
25 mg
£4673.00
DHH28810-25MG
About this Product
- SKU:
- DHH28810
- Additional Names:
- Bispecific, LY 3090106, LY-3090106, LY3090106, CAS: 1849636-24-3
- Buffer:
- 0.01M PBS, pH 7.4.
- translate.label.attr.clone:
- Tibulizumab
- Clonality:
- Recombinant Monoclonal
- Host:
- Human
- Immunogen:
- CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor
- Isotype:
- IgG4, kappa
- Physical State:
- Liquid
- Purity:
- >95%
- Purification:
- Protein A/G purified from cell culture supernatant.
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- AntibodySystem
- Type:
- Antibody: Recombinant Antibodies
